Issue navigation
Volume 10, Issue 5, October 2023
Editorials
Overcoming the exclusion of marginalized caregiver and patient groups in pediatric brain tumor research
Neuro-Oncology Practice, Volume 10, Issue 5, October 2023, Pages 403–405, https://doi.org/10.1093/nop/npad030
Neuro-oncology in the crosshairs during the coronavirus disease 2019 pandemic
Neuro-Oncology Practice, Volume 10, Issue 5, October 2023, Pages 406–407, https://doi.org/10.1093/nop/npad029
Review
Psychosocial interventions for personality and behavior changes in adults with a brain tumor: A scoping review
Neuro-Oncology Practice, Volume 10, Issue 5, October 2023, Pages 408–417, https://doi.org/10.1093/nop/npad031
Original Articles
Caregivers matter: Neurological vulnerability for pediatric brain tumor survivors
Neuro-Oncology Practice, Volume 10, Issue 5, October 2023, Pages 418–428, https://doi.org/10.1093/nop/npad010
Neurosurgical care for patients with high-grade gliomas during the coronavirus disease 2019 pandemic: Analysis of routine billing data of a German nationwide hospital network
Neuro-Oncology Practice, Volume 10, Issue 5, October 2023, Pages 429–436, https://doi.org/10.1093/nop/npad015
The effects of educational interventions and the COVID-19 pandemic on the time to diagnosis in pediatric patients with primary central nervous system tumors
Neuro-Oncology Practice, Volume 10, Issue 5, October 2023, Pages 437–445, https://doi.org/10.1093/nop/npad024
Does the distance to the cancer center affect psycho-oncological care and emergency visits of patients with IDH wild-type gliomas? A retrospective study
Neuro-Oncology Practice, Volume 10, Issue 5, October 2023, Pages 446–453, https://doi.org/10.1093/nop/npad023
Exploring the clinical utility of a brief screening measure of unmet supportive care needs in people with high-grade glioma
Neuro-Oncology Practice, Volume 10, Issue 5, October 2023, Pages 454–461, https://doi.org/10.1093/nop/npad035
Epigenetic profiling reveals a strong association between lack of 5-ALA fluorescence and EGFR amplification in IDH-wildtype glioblastoma
Neuro-Oncology Practice, Volume 10, Issue 5, October 2023, Pages 462–471, https://doi.org/10.1093/nop/npad025
An evaluation of biobanking and therapeutic clinical trial representation among adult glioma patients from rural and urban Utah
Neuro-Oncology Practice, Volume 10, Issue 5, October 2023, Pages 472–481, https://doi.org/10.1093/nop/npad026
Prevalence of pathogenic germline variants in adult-type diffuse glioma
Neuro-Oncology Practice, Volume 10, Issue 5, October 2023, Pages 482–490, https://doi.org/10.1093/nop/npad033
Letters to the Editor
Letter regarding “Acceptability and feasibility of neurocognitive assessments with adults with primary brain cancer and brain metastasis: A systematic review”
Neuro-Oncology Practice, Volume 10, Issue 5, October 2023, Pages 491–492, https://doi.org/10.1093/nop/npad043
Response to Gorter et al. regarding “Acceptability and feasibility of neurocognitive assessments with adults with primary brain cancer and brain metastases: A systematic review”
Neuro-Oncology Practice, Volume 10, Issue 5, October 2023, Pages 493–494, https://doi.org/10.1093/nop/npad042
Society News
Forthcoming Meetings
Neuro-Oncology Practice, Volume 10, Issue 5, October 2023, Page 495, https://doi.org/10.1093/nop/npad052
